Caris Life Sciences Unveils Groundbreaking Study on Blood-Based Assay for Multi-Cancer Detection
Caris Life Sciences' New Study Unveils Potential of Blood-Based Cancer Detection
Caris Life Sciences, a pioneering company in precision medicine, has recently published a remarkable study in the prestigious journal Scientific Reports from Nature, unveiling the clinical utility of its innovative Caris Assure® blood-based assay. This next-generation diagnostic tool holds the promise of transforming the landscape of cancer detection and management.
What is the Caris Assure® Assay?
The Caris Assure® platform is designed to be more than just a standard liquid biopsy test. It is a comprehensive assay that combines both Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) performed on a single platform while employing cutting-edge machine learning techniques. This unique combination allows for a detailed molecular profiling of over 23,000 genes present in plasma and the
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.